Atlas Trials

Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation

Clinical trial NCT01856543 · COMPLETED

Trial details

NCT number
NCT01856543
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Invasive Breast Cancer
Start date
2013-05-01
Primary completion
2017-01-01
Enrollment
143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.